Bayerische Motoren Werke ADR (BMWYY)

TransCode Therapeutics (NASDAQ: RNAZ) announced the submission of an Investigational New Drug (“IND”) application amendment to the U.S. Food and Drug Administration for a planned Phase 2a clinical trial of its lead candidate, TTX-MC138, to be conducted by Quantum Leap Healthcare Collaborative within the PRE-I-SPY program. The dose-expansion study is expected to enroll up to 45 colorectal cancer patients who have completed standard curative-intent therapy and test positive for circulating tumor DNA (“ctDNA”), a marker associated with minimal residual disease (“MRD”) and cancer recurrence, with the trial planned to begin in the first half of 2026 under the leadership of Dr. Paula Pohlmann of MD Anderson Cancer Center.

Telomir Pharmaceuticals (NASDAQ: TELO) announced new cellular study results showing that Telomir-1, administered as Telomir-Zn, induces a rapid and coordinated redistribution of intracellular metals, simultaneously increasing zinc levels while reducing redox-active ferrous iron in living cells. The company said the findings extend its previously reported iron-reduction data by demonstrating, for the first time, a coupled intracellular metal-modulating mechanism rather than simple extracellular chelation, supporting a potential upstream approach to addressing oxidative stress, mitochondrial dysfunction, epigenetic instability, and genomic damage associated with cancer and aging.

In the microcap market, capital formation is often synonymous with dilution. Companies raise money by issuing new shares, frequently at the expense of long-term shareholders, creating a cycle where growth in operations does not translate into growth in per-share value. Against that backdrop, capital discipline itself becomes a differentiator, and increasingly, a signal of management intent.

Researchers have developed a technological platform that leverages yeast cells to test and understand new cancer treatments under development. The use of this platform promises to significantly reduce the costs and time needed in the drug development process.

Auto lease services in Feasterville-Trevose have shifted as VIP Auto PA continues to gain recognition for its no-haggle approach to vehicle acquisition. Operating from 2399 Old Lincoln Hwy, the company has been serving Pennsylvania drivers since 2007 with a business model that prioritizes straightforward transactions over traditional dealership tactics.

Despite decades of progress in oncology, many cancers remain resistant to treatment, not because therapies are unavailable, but because tumor cells adapt. Immunotherapies and chemotherapies can produce meaningful responses, yet durability and consistency remain challenges, particularly in aggressive or rare cancer subtypes. Increasingly, research is shifting toward approaches that improve how well existing treatments work, rather than introducing entirely new drugs.

LuxuryCars.ng has officially launched a premium online automotive marketplace designed to connect Nigerian buyers with verified sellers of foreign used (Tokunbo) luxury vehicles, introducing a more transparent and structured approach to high-end car transactions nationwide.

Oragenics (NYSE American: OGEN) announced that it has engaged DUCK FLATS Pharma as its U.S. Investigational New Drug readiness and regulatory execution partner to support FDA-facing preparation and clinical trial design as the Company advances its intranasal concussion therapy ONP-002 toward U.S.-based development, with the engagement intended to align the Company’s upcoming Phase 2a clinical trial in Australia with its U.S. regulatory strategy and support progression toward a future U.S. Phase 2b trial and later-stage development.

According to recent data, health expenditures in the U.S. reached $5.3 trillion in 2024 . That figure equates to 18% of GDP, and is double what is spent on average in other developed countries. Americans are feeling the pinch, and an estimated 100 million individuals in the country have medical debt.

Cutaneous T-cell lymphoma (“CTCL”) remains a cancer with limited treatment options, persistent symptoms and long-term quality-of-life challenges for patients, even decades after its classification as a distinct disease. Despite medical advances in oncology, many people living with CTCL continue to cycle through therapies that offer only partial relief or introduce new burdens. Soligenix (NASDAQ: SNGX) is advancing new treatment approaches focused on improving tolerability and long-term quality of life for patients living with this rare cancer.

VenHub Global, Inc. (NASDAQ:VHUB) (“VenHub” or the “Company”), a leader in fully autonomous Smart Store technology, today announced the appointment of Ian Rasmussen as

As the global burden of rare diseases continues to rise, there is increasing urgency for innovative therapies that address unmet medical needs. More than 300 million people worldwide live with one or more rare diseases, many of which have limited or no approved treatment options, and diagnostic delays can persist for years, prolonging suffering and reducing quality of life. Amid this growing demand, Soligenix (NASDAQ: SNGX) is advancing a diversified pipeline of specialized biotherapeutics and public health solutions targeting rare and orphan conditions as it heads into 2026.

Nutriband (NASDAQ: NTRB) (NASDAQ: NTRBW) provided shareholders with an update following its 2026 Annual Shareholders Meeting held Jan. 24, 2026, in Orlando, Florida, highlighting the appointment of two new directors, Alessandro Puddu and Viorica Carlig, and outlining key progress in the development of AVERSA(TM) FENTANYL. During 2025, the company strengthened its exclusive partnership with Kindeva, completed commercial manufacturing scale-up, expanded global patent protection including new U.S. and Macao patents, engaged with the U.S. Food and Drug Administration through a Type C meeting, and advanced branding initiatives for AVERSA(TM) FENTANYL. Looking ahead to 2026, Nutriband plans to advance toward an NDA filing by extending patent protection potentially to 2046, manufacturing clinical supplies, filing an Investigational New Drug application, and initiating a Human Abuse Liability clinical study.

Researchers at the University of Chicago have identified a compound that has shown efficacy in shrinking tumors in the brains of mice. This has created hope that the compound could, in future, be made into a pill that can treat glioblastoma, one of the deadliest forms of brain cancer.

In many over-the-counter (“OTC”) markets, capitalization structures are often diluted, and the incentives of management are misaligned, which may leave leadership unmotivated. However, Earth Science Tech (OTC: ETST), a strategic holding company, flips this idea on its head.

Scientists have found that keeping circadian rhythms, the variations in body processes during the course of the day, in mind while administering immunotherapy could hold the key to boosting treatment outcomes in patients with cancer.

In today’s increasingly competitive digital asset industry, how can platforms achieve deep user engagement and mutual growth? Global leading digital asset service platform BitradeX has provided an ambitious answer. The company officially announces the launch of an industry-defining growth campaign, the “2026 BitradeX Anniversary Luxury Sports Car Team Battle Invitational.” This event features a million-dollar cash prize pool and high-value luxury car rewards, including a Porsche 911 and BMW Z4. The event aims to explore a new user growth model based on social virality and team honor through a four-month competition.

When elegance, punctuality and professionalism are of the utmost importance, Paris Orly chauffeur service by Noble Transfer offers a travel experience that goes beyond. Whether you are flying in for business, leisure or a special event, you deserve a flying service that combines luxury with reliability -- the kind of refinement that is sure to make every moment in Paris unforgettable.

The United States has formally communicated its immediate withdrawal from the World Health Organization (WHO), denying the global body one of its largest donors. The withdrawal follows the signing of an executive order to this effect during the first months of Trump’s current administration.

Las Vegas-based company, All European Auto Repair, is pleased to announce that the knowledgeable and experienced mechanics are ASE-certified and can handle any vehicle problem that customers might be faced with, but the company specializes in the repair of luxury vehicles such as Mercedes-Benz, Rolls-Royce, Jaguar, BMW, Bentley, Audi, and Range Rover. The services range from oil changes and engine diagnostics to belt and hose repairs, air conditioning, brake repairs, tire and wheel services, and suspension services. The services are performed by expert mechanics who provide additional perks and amenities.

Big Mission Automotive is committed to operating as the premier European auto repair shop serving Colorado Springs, Denver, Castle Rock, Monument, and the entire Front Range. Designed specifically for discerning Audi, BMW, Mercedes-Benz, Mini, Porsche, and Volkswagen owners who have grown tired of impersonal dealership experiences and inflated pricing, Big Mission has emerged as the trusted resource for specialized, relationship-driven automotive care in Colorado.

Earth Science Tech (OTC: ETST), a strategic holding company advancing a portfolio of operating businesses within regulated healthcare markets, announced that it has engaged InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, to assist with its corporate communications strategy, reflecting the company’s focus on execution, compliance and disciplined scaling across licensed pharmaceutical compounding, digital health and telemedicine platforms, specialty healthcare services and complementary assets, with hands-on operational oversight through wholly owned and majority-owned subsidiaries aimed at building sustainable revenue streams and long-term shareholder value.

Psoriasis is a chronic skin condition that afflicts at least 60 million individuals globally. Nearly 80% of these affected people also tend to be either overweight or obese. Excess weight has been a known risk factor for psoriasis development, but until now, no rigorous scientific data existed on how the quality of life of patients and the disease severity are impacted when interventions to reduce weight are instituted for psoriatic patients.

Limo SF VIP has announced the availability of limousine and corporate shuttle car services for business travelers in San Jose.

Researchers at the University of Michigan (U-M) have developed a system that leverages both AI and machine learning to create a digital twin of a patient’s brain cancer in order to predict how that patient will respond to different treatments. This tool promises to take personalized cancer care a step higher.